PRTA Q1 2018 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$227,000-12.4% YoY

Gross Profit

-$34M-15189.0% margin

Operating Income

-$49M-21457.3% margin

Net Income

-$49M-21472.7% margin

EPS (Diluted)

$-1.26

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$607M

Total Liabilities

$197M

Stockholders' Equity

$410M

Cash & Equivalents

$429M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$227,000	$259,000	-12.4%
Gross Profit	-$34M	-$25M	-35.5%
Operating Income	-$49M	-$36M	-34.3%
Net Income	-$49M	-$35M	-37.8%